Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil

CoordenaÃÃo de AperfeÃoamento de Pessoal de NÃvel Superior === Cervical cancer was responsible for the death of 265,000 women in the world in 2012. With the exception of skin cancer, this tumor is the one with the greatest potential for prevention and cure when diagnosed early. The conventional Pap...

Full description

Bibliographic Details
Main Author: Paula Bruno Monteiro
Other Authors: Francisco HerlÃnio Costa Carvalho
Format: Others
Language:Portuguese
Published: Universidade Federal do Cearà 2016
Subjects:
Online Access:http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=17484
id ndltd-IBICT-oai-www.teses.ufc.br-11223
record_format oai_dc
collection NDLTD
language Portuguese
format Others
sources NDLTD
topic SAUDE COLETIVA
spellingShingle SAUDE COLETIVA
Paula Bruno Monteiro
Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
description CoordenaÃÃo de AperfeÃoamento de Pessoal de NÃvel Superior === Cervical cancer was responsible for the death of 265,000 women in the world in 2012. With the exception of skin cancer, this tumor is the one with the greatest potential for prevention and cure when diagnosed early. The conventional Pap test (Papanicolaou) is the main strategy of screening programs for cervical cancer in Brazil and worldwide. It is known that, in developing countries, many women only seek health services when they show symptoms of disease or during pregnancy. Therefore, pregnancy can be a good opportunity to conduct a Pap smear with the aim of preventing cervical cancer. This study had the objective of assess the dynamics of offering and performing cytology collection for screening cervical cancer in pregnant women in Fortaleza-CE. This is a descriptive cross-sectional study with a quantitative approach. The research was conducted at the Maternity School Assis Chateaubriand (MEAC), with a sample of 318 patients. Univariate and multivariate analysis was performed using SPSS statistical software. Only 11% of all patients and 10.8% of patients over 25 years took advantage of the prenatal consultations to make the Pap smear. Among the 283 (89%) patients who did not realize cervical cancer prevention in pregnancy, the majority, 80.9%, did not do it because the health professional had not offered. In the analysis of demographic and socioeconomic variables, the group of patients who were employed at the time showed the highest prevalence of taking the exam during pregnancy compared to women who did not work (PR: 2.19; 95% CI 1.00 to 4.87; p: 0.043). Patients that had the pregnancy considered high risk pregnancy (PR: 3.15; 95% CI 1.52 to 6.54; p <0.001), that had prenatal care at MEAC (PR: 2.77; 95% CI 1.48 -5.19; p 0.001), that made all consultations with a physician (PR: 2.95; 95% CI 1.53 to 5.69; p: 0.003), that did not have a health center close to home (PR: 3.22; 95% CI 1.44 to 7.21; p: 0.026) and that knew that the exam could be done during pregnancy (PR: 5.05; 95% CI 2.16 to 11.83; p <0.001) had significantly higher prevalence of having their Pap smear performed during prenatal care. It can be concluded that the frequency of offering and the realization of cervical cytological collection was very low and that it is necessary to conduct awareness programs for health professionals on the importance and safety of performing the prevention of cervical cancer during prenatal visits === O cÃncer de colo uterino foi responsÃvel pelo Ãbito de 265 mil mulheres no mundo em 2012. Com exceÃÃo do cÃncer de pele, esse tumor à o que apresenta maior potencial de prevenÃÃo e cura, quando diagnosticado precocemente. O teste citopatolÃgico convencional (Papanicolaou) à a principal estratÃgia de programas de rastreamento do cÃncer do colo do Ãtero no Brasil e no mundo. Sabe-se que, em paÃses em desenvolvimento, muitas mulheres sà procuram os ServiÃos de SaÃde quando apresentam sintomas de doenÃas ou durante a gravidez. Portanto, a gravidez pode ser uma boa oportunidade de realizar uma colpocitologia com o objetivo de prevenÃÃo do cÃncer do colo uterino. O presente estudo teve o objetivo de avaliar a dinÃmica de oferecimento e realizaÃÃo de coleta de citologia oncÃtica para rastreamento de cÃncer de colo uterino em gestantes em Fortaleza-CE. Trata-se de um estudo descritivo de abordagem quantitativa do tipo transversal. A pesquisa foi desenvolvida na Maternidade Escola Assis Chateaubriand, com amostra de 318 pacientes. Para anÃlise univariada e bivariada foi utilizado o programa estatÃstico SPSS. Apenas 11% das pacientes aproveitaram as consultas prÃ-natais para realizar o exame citopatolÃgico do colo do Ãtero. Entre as 283 (89%) pacientes que nÃo realizaram sua prevenÃÃo de cÃncer de colo uterino na gestaÃÃo, a grande maioria, 80,9% nÃo o fez devido o profissional de saÃde nÃo ter oferecido. Na anÃlise das variÃveis demogrÃficas e socioeconÃmicas, o grupo de pacientes que exerciam atividade remunerada apresentou prevalÃncia maior, estatisticamente significante, de realizar o exame durante a gravidez quando comparadas Ãs mulheres que nÃo trabalhavam (RP: 2,19; IC95%1,00-4,87; p: 0,043). Pacientes cuja gravidez foi considerada de alto risco (RP: 3,15; IC95%1,52-6,54; p<0,001), que fizeram o prÃ-natal na MEAC (RP: 2,77; IC95% 1,48-5,19; p0,001), que realizaram todas as consultas com mÃdico (RP: 2,95; IC95% 1,53-5,69; p: 0,003), nÃo ter posto de saÃde perto de casa (RP: 3,22; IC95% 1,44-7,21; p: 0,026) e consciÃncia do nÃo risco da coleta durante a gestaÃÃo (RP: 5,05; IC95% 2,16-11,83; p < 0,001) apresentaram prevalÃncia significativamente maior de terem seu exame citopatolÃgico realizado durante o prÃ-natal. Pode-se concluir que a frequÃncia de oferecimento e realizaÃÃo da coleta colpocitolÃgica à muito baixa e que à necessÃrio realizar programas de conscientizaÃÃo dos profissionais de saÃde da importÃncia e seguranÃa da realizaÃÃo da prevenÃÃo do cÃncer de colo uterino durante as consultas prÃ-natais.
author2 Francisco HerlÃnio Costa Carvalho
author_facet Francisco HerlÃnio Costa Carvalho
Paula Bruno Monteiro
author Paula Bruno Monteiro
author_sort Paula Bruno Monteiro
title Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_short Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_full Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_fullStr Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_full_unstemmed Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil
title_sort dynamics of offering and realization the cytology for cervical cancer in pregnant women in fortaleza ceara brasil
publisher Universidade Federal do CearÃ
publishDate 2016
url http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=17484
work_keys_str_mv AT paulabrunomonteiro dynamicsofofferingandrealizationthecytologyforcervicalcancerinpregnantwomeninfortalezacearabrasil
AT paulabrunomonteiro dinamicadeoferecimentoerealizaaaodacitologiaemgestantedefortaleza
_version_ 1718902910116429824
spelling ndltd-IBICT-oai-www.teses.ufc.br-112232019-01-21T23:09:56Z Dynamics of offering and realization the cytology for cervical cancer in pregnant women in Fortaleza Ceara Brasil DinÃmica de oferecimento e realizaÃÃo da citologia em gestante de Fortaleza Paula Bruno Monteiro Francisco HerlÃnio Costa Carvalho Luciano Lima Correia Josà EleutÃrio JÃnior SAUDE COLETIVA CoordenaÃÃo de AperfeÃoamento de Pessoal de NÃvel Superior Cervical cancer was responsible for the death of 265,000 women in the world in 2012. With the exception of skin cancer, this tumor is the one with the greatest potential for prevention and cure when diagnosed early. The conventional Pap test (Papanicolaou) is the main strategy of screening programs for cervical cancer in Brazil and worldwide. It is known that, in developing countries, many women only seek health services when they show symptoms of disease or during pregnancy. Therefore, pregnancy can be a good opportunity to conduct a Pap smear with the aim of preventing cervical cancer. This study had the objective of assess the dynamics of offering and performing cytology collection for screening cervical cancer in pregnant women in Fortaleza-CE. This is a descriptive cross-sectional study with a quantitative approach. The research was conducted at the Maternity School Assis Chateaubriand (MEAC), with a sample of 318 patients. Univariate and multivariate analysis was performed using SPSS statistical software. Only 11% of all patients and 10.8% of patients over 25 years took advantage of the prenatal consultations to make the Pap smear. Among the 283 (89%) patients who did not realize cervical cancer prevention in pregnancy, the majority, 80.9%, did not do it because the health professional had not offered. In the analysis of demographic and socioeconomic variables, the group of patients who were employed at the time showed the highest prevalence of taking the exam during pregnancy compared to women who did not work (PR: 2.19; 95% CI 1.00 to 4.87; p: 0.043). Patients that had the pregnancy considered high risk pregnancy (PR: 3.15; 95% CI 1.52 to 6.54; p <0.001), that had prenatal care at MEAC (PR: 2.77; 95% CI 1.48 -5.19; p 0.001), that made all consultations with a physician (PR: 2.95; 95% CI 1.53 to 5.69; p: 0.003), that did not have a health center close to home (PR: 3.22; 95% CI 1.44 to 7.21; p: 0.026) and that knew that the exam could be done during pregnancy (PR: 5.05; 95% CI 2.16 to 11.83; p <0.001) had significantly higher prevalence of having their Pap smear performed during prenatal care. It can be concluded that the frequency of offering and the realization of cervical cytological collection was very low and that it is necessary to conduct awareness programs for health professionals on the importance and safety of performing the prevention of cervical cancer during prenatal visits O cÃncer de colo uterino foi responsÃvel pelo Ãbito de 265 mil mulheres no mundo em 2012. Com exceÃÃo do cÃncer de pele, esse tumor à o que apresenta maior potencial de prevenÃÃo e cura, quando diagnosticado precocemente. O teste citopatolÃgico convencional (Papanicolaou) à a principal estratÃgia de programas de rastreamento do cÃncer do colo do Ãtero no Brasil e no mundo. Sabe-se que, em paÃses em desenvolvimento, muitas mulheres sà procuram os ServiÃos de SaÃde quando apresentam sintomas de doenÃas ou durante a gravidez. Portanto, a gravidez pode ser uma boa oportunidade de realizar uma colpocitologia com o objetivo de prevenÃÃo do cÃncer do colo uterino. O presente estudo teve o objetivo de avaliar a dinÃmica de oferecimento e realizaÃÃo de coleta de citologia oncÃtica para rastreamento de cÃncer de colo uterino em gestantes em Fortaleza-CE. Trata-se de um estudo descritivo de abordagem quantitativa do tipo transversal. A pesquisa foi desenvolvida na Maternidade Escola Assis Chateaubriand, com amostra de 318 pacientes. Para anÃlise univariada e bivariada foi utilizado o programa estatÃstico SPSS. Apenas 11% das pacientes aproveitaram as consultas prÃ-natais para realizar o exame citopatolÃgico do colo do Ãtero. Entre as 283 (89%) pacientes que nÃo realizaram sua prevenÃÃo de cÃncer de colo uterino na gestaÃÃo, a grande maioria, 80,9% nÃo o fez devido o profissional de saÃde nÃo ter oferecido. Na anÃlise das variÃveis demogrÃficas e socioeconÃmicas, o grupo de pacientes que exerciam atividade remunerada apresentou prevalÃncia maior, estatisticamente significante, de realizar o exame durante a gravidez quando comparadas Ãs mulheres que nÃo trabalhavam (RP: 2,19; IC95%1,00-4,87; p: 0,043). Pacientes cuja gravidez foi considerada de alto risco (RP: 3,15; IC95%1,52-6,54; p<0,001), que fizeram o prÃ-natal na MEAC (RP: 2,77; IC95% 1,48-5,19; p0,001), que realizaram todas as consultas com mÃdico (RP: 2,95; IC95% 1,53-5,69; p: 0,003), nÃo ter posto de saÃde perto de casa (RP: 3,22; IC95% 1,44-7,21; p: 0,026) e consciÃncia do nÃo risco da coleta durante a gestaÃÃo (RP: 5,05; IC95% 2,16-11,83; p < 0,001) apresentaram prevalÃncia significativamente maior de terem seu exame citopatolÃgico realizado durante o prÃ-natal. Pode-se concluir que a frequÃncia de oferecimento e realizaÃÃo da coleta colpocitolÃgica à muito baixa e que à necessÃrio realizar programas de conscientizaÃÃo dos profissionais de saÃde da importÃncia e seguranÃa da realizaÃÃo da prevenÃÃo do cÃncer de colo uterino durante as consultas prÃ-natais. 2016-02-24 info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/masterThesis http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=17484 por info:eu-repo/semantics/openAccess application/pdf Universidade Federal do Cearà Programa de PÃs-GraduaÃÃo em SaÃde PÃblica UFC BR reponame:Biblioteca Digital de Teses e Dissertações da UFC instname:Universidade Federal do Ceará instacron:UFC